Autopsy report · NCT05627388

Feasibility Study of At-Home EEG Monitoring for Hypersomnia

“Study was never started. The research protocol was redeveloped and submitted as a new study therefore we would like to close this study.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Kaiser Permanente

Sponsor type

University, hospital or other

Conditions

Hypersomnia; Narcolepsy

Interventions

Dreem 3 System At-Home Monitoring

Participants

0

Trials that died the same way

• Multi-Modality Imaging for Head & Neck Cancer Free Flap Design Assessment
  “We are closing this study due to the focus on other research projects and there is no time or personnel tofurther pursue the completion of this project” (75% match in meaning)
• Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia
  “The study was closed after \> 1 year of inactivity.” (74% match in meaning)
• Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia
  “The study was closed due to the end of funding.” (73% match in meaning)
• Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer
  “The study was never initiated, no patients were enrolled. It has been closed with the IRB.” (70% match in meaning)
• A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
  “The study was closed by the Sponsor according to the protocol-specified minimum post-treatment follow-up period of 3 years.” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.